| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |